Renin-angiotensin system inhibitors prescriptions in Chinese hospitalized chronic kidney disease patients

Table 4 Multivariate logistic regression on characteristics associated with renin-angiotensin system inhibitors prescriptions in guideline-recommended chronic kidney disease patients

Characteristics	P value	Odds ratio (95%CI)
Gender, male versus female	0.020	1.089 (1.014, 1.170)
Year of admission	< 0.001
2012-2013		3.795 (3.384, 4.255)
2014-2015		4.799 (4.269, 5.394)
2016-2017		4.648 (4.117, 5.247)
2018-2019		2.913 (2.589, 3.276)
Age, yr	< 0.001
60 ≤ age < 70	0.008	0.873 (0.790, 0.964)
70 ≤ age < 80	0.001	0.767 (0.660, 0.891)
80 ≤ age < 90	0.008	0.639 (0.459, 0.889)
≥ 90	0.290	0.320 (0.039, 2.647)
Diastolic blood pressure	< 0.001
≥ 90 mmHg	< 0.001	1.195 (1.110, 1.287)
< 60 mmHg	0.004	0.666 (0.506, 0.877)
Department	< 0.001
Cardiology	< 0.001	0.731 (0.624, 0.857)
Endocrinology	< 0.001	0.523 (0.459, 0.595)
Neurology	< 0.001	0.361 (0.221, 0.591)
Pulmonary	< 0.001	0.113 (0.061, 0.208)
Surgery	< 0.001	0.107 (0.068, 0.169)
Others	< 0.001	0.299 (0.260, 0.344)
Stage of CKD	< 0.001
CKD2	0.548	1.031 (0.933, 1.139)
CKD3	< 0.001	0.808 (0.732, 0.890)
CKD4	< 0.001	0.245 (0.217, 0.277)
CKD5	< 0.001	0.880 (0.077, 0.101)
Acute kidney injury	0.003	0.835 (0.742, 0.939)
Hypertension	< 0.001	2.513 (2.318, 2.724)
Diabetes	< 0.001	1.218 (1.118, 1.327)
IgA nephropathy	< 0.001	1.498 (1.368, 1.640)
Heart failure	0.045	0.825 (0.685, 0.995)
Proteinuria	< 0.001	1.400 (1.227, 1.597)

CKD: Chronic kidney disease.